266 related articles for article (PubMed ID: 15003661)
1. Sero-epidemiology of Bordetella pertussis in England and Wales.
Nardone A; Pebody RG; Maple PA; Andrews N; Gay NJ; Miller E
Vaccine; 2004 Mar; 22(9-10):1314-9. PubMed ID: 15003661
[TBL] [Abstract][Full Text] [Related]
2. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.
Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D
Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250
[TBL] [Abstract][Full Text] [Related]
3. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China.
Wang CQ; Zhu QR
Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough.
Kapaskelis AM; Vouloumanou EK; Rafailidis PI; Hatzopoulou P; Nikita D; Falagas ME
Respir Med; 2008 Nov; 102(11):1586-91. PubMed ID: 18684605
[TBL] [Abstract][Full Text] [Related]
7. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
8. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population.
Lau RC
N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
[TBL] [Abstract][Full Text] [Related]
10. Frequency of pertussis in children with prolongued cough.
Yildirim I; Ceyhan M; Kalayci O; Cengiz AB; Secmeer G; Gur D; Pelton S
Scand J Infect Dis; 2008; 40(4):314-9. PubMed ID: 17934983
[TBL] [Abstract][Full Text] [Related]
11. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
[TBL] [Abstract][Full Text] [Related]
12. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.
Aase A; Herstad TK; Merino S; Brandsdal KT; Berdal BP; Aleksandersen EM; Aaberge IS
Clin Vaccine Immunol; 2007 Jul; 14(7):855-62. PubMed ID: 17507542
[TBL] [Abstract][Full Text] [Related]
13. The utility of seroepidemiology for tracking trends in pertussis infection.
Quinn HE; McIntyre PB; Backhouse JL; Gidding HF; Brotherton J; Gilbert GL
Epidemiol Infect; 2010 Mar; 138(3):426-33. PubMed ID: 19719902
[TBL] [Abstract][Full Text] [Related]
14. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.
Strebel P; Nordin J; Edwards K; Hunt J; Besser J; Burns S; Amundson G; Baughman A; Wattigney W
J Infect Dis; 2001 May; 183(9):1353-9. PubMed ID: 11294666
[TBL] [Abstract][Full Text] [Related]
15. Survey of pertussis in patients with prolonged cough.
Hu JJ; Lu CY; Chang LY; Huang CH; Chou CC; Huang FY; Lee CY; Huang LM
J Microbiol Immunol Infect; 2006 Feb; 39(1):54-8. PubMed ID: 16440124
[TBL] [Abstract][Full Text] [Related]
16. The relationship between pertussis symptomatology, incidence and serology in adolescents.
Cagney M; McIntyre PB; Heron L; Giammanco A; MacIntyre CR
Vaccine; 2008 Oct; 26(44):5547-53. PubMed ID: 18723066
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey.
Ozkal A; Sensoy G; Acuner C; Belet N; Güney AK
Turk J Pediatr; 2012; 54(1):15-9. PubMed ID: 22397036
[TBL] [Abstract][Full Text] [Related]
18. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
Chodorowska M
Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
[TBL] [Abstract][Full Text] [Related]
19. Serodiagnosis of whooping cough in Belgium: results of the National Reference Centre for Bordetella pertussis anno 2013.
Duterme S; Vanhoof R; Vanderpas J; Pierard D; Huygen K
Acta Clin Belg; 2016 Apr; 71(2):86-91. PubMed ID: 27075799
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
